成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antineoplastic agents>Hormonal antineoplastic drugs>Tamoxifen citrate
Tamoxifen citrate
  • Tamoxifen citrate

Tamoxifen citrate

Price $1
Package 1KG
Min. Order: 1G
Supply Ability: 100KG
Update Time: 2019-07-06

Product Details

Product Name: Tamoxifen citrate CAS No.: 54965-24-1
Min. Order: 1G Purity: 98%
Supply Ability: 100KG Release date: 2019/07/06

AD68

Tamoxifen citrate Basic information
Indications and Usage Mechanism of action Pharmacodynamics Side Effects
Product Name: Tamoxifen citrate
Synonyms: 1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;(z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethanamine,citrate(1:;(z)-2-(para-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylaminecitrate(;2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethyl-ethanamin(z)-ethanamin2-hydrox;ici46,474;kessar;noltam;tamofen
CAS: 54965-24-1
MF: C32H37NO8
MW: 563.64
EINECS: 259-415-2
Product Categories: Active Pharmaceutical Ingredients;Antitumors for Research and Experimental Use;Biochemistry;API's;Intracellular receptor;Steroid and Hormone;API;SOLTAMOX;Inhibitors
Mol File: 54965-24-1.mol
Article illustration
 
Tamoxifen citrate Chemical Properties
Melting point  140-144 °C
storage temp.  2-8°C
solubility  methanol: soluble50mg/mL, clear, colorless
form  Powder
color  White to off-white
Water Solubility  slightly soluble
Sensitive  Light Sensitive & Hygroscopic
Merck  14,9048
CAS DataBase Reference 54965-24-1(CAS DataBase Reference)
EPA Substance Registry System Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1- butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)(54965-24-1)
 
Safety Information
Hazard Codes  T,Xi
Risk Statements  45-60-61-22-64-36/37/38
Safety Statements  53-36/37/39-45-36-26
RIDADR  UN 3077 9 / PGIII
WGK Germany  3
RTECS  KH2387000
HazardClass  IRRITANT
Toxicity LD50 in mice, rats (mg/kg): 200, 600 i.p.; 62.5, 62.5 i.v.; 3000-6000, 1200-2500 orally (Furr, Jordan)
Tamoxifen citrate Usage And Synthesis
Indications and Usage Tamoxifen Citrate Tablets (TCT) is a competitive estrogen antagonist and a nonsteroidal anti-estrogen drug. It is commonly used clinically to treat all forms of breast cancer, and it is especially suitable for postmenopausal female breast cancer patients who are estrogen receptor and progesterone receptor positive and have relatively low levels of prostrate specific antigens. Tamoxifen citrate has anti-tumor and anti-drug resistance effects, and it can be used for heart protection and treating advanced recurrent breast cancer and ovarian cancer.
Mechanism of action Tamoxifen citrate has cis-trans isomers, with its cis isomers having extremely weak estrogen activity, and its trans isomers having anti-estrogen effects. When tamoxifen citrate is first being used or at a low concentration, it binds with breast cancer cells’ estrogen receptors (ER) in the cytoplasm, thus having a weak estrogen activity. After tamoxifen citrate enters the nucleus, it inhibits the transcription and synthesis of breast cancer cell ER in the nucleus, which achieves a lasting anti-estrogen effect. This inhibits estrogen’s effects on cancer cells, which obstructs cancer cell growth and maturation, thus having an anti-tumor effect. Studies have found that tamoxifen citrate’s many new functions are related to a mechanism separate from its competitive estrogen receptor – its membrane regulating mechanism. As a membrane regulator, tamoxifen citrate can decrease cell circulation, and it an also act as an antioxidant to product the cell membrane and prevent low density lipoproteins from being damaged by oxidation. Tamoxifen citrate lowers membrane fluidity and strengthens intercellular binding sites to lower the concentration and activity of cancer metastasis promoters and active enzymes, thus inhibiting or preventing cancer cell growth and metastasis. Additionally, it promotes cells surrounding tumor lesions to secrete negative growth factors (transforming growth factor (TGF-G)) to control the spread of cancer cells. It can also inhibit the hydrogen peroxide produced by human neutral white blood cells from oxidizing and damaging DNA bases, thus aiding in the treatment and prevention of all kinds of malignant tumors, and it has been tested for treating brain cancer, liver cancer, prostate cancer, etc. By lowering membrane fluidity, tamoxifen citrate can also lower the release effect of P170 glycoproteins on the cell membrane and increase the effective concentration of cytotoxic drugs in cells and lower drug resistance.
Pharmacodynamics Tamoxifen citrate tablets are taken orally and absorbed slowly, taking about 3-6 hours to reach peak blood concentration. After absorption, tamoxifen citrate tablets’ liver metabolite is N- desmethyl tamoxifen, which has similar activity to tamoxifen citrate. The drug’s clearing half-life is 5-7 days and its metabolite N-desmethyl tamoxifen’s half-life is 7-14 days. Animal trials show that tamoxifen citrate and N-desmethyl tamoxifen are widely circulated in the intestines and liver. For a single 20mg dose of tamoxifen citrate, its peak blood values are 40ng/ml (range: 67-183ng/ml) and 336ng/ml (range: 148-654ng/ml). Tamoxifan citrate reaches a stable blood concentration after consistent use for 3-4 weeks, while N-desmethyl tamoxifen requires 3-8 weeks. Tamoxifen citrate and its metabolites are mainly excreted in feces, and a small amount of metabolites is excreted in urine.
Side Effects Common adverse effects include nausea, vomiting, facial flushing, and other mild symptoms.
Chemical Properties white to off-white powder
Uses estrogen antagonist, antineoplastic
Uses anti-estrogen, protein kinase C inhibitor, beneficial cardiovascular effects, bone cancer treatment, induces DNA adduct formation
Uses An antiestrogen with potent anti-cancer and PKC inhibitory activities
Biological Activity Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30.
 

Company Profile Introduction

Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals. Mainly deals in the sales of: Pharmaceutical intermediates OLED intermediates: Pharmaceutical intermediates; OLED intermediates;

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1Box
VIP1Y
American HealthyMorph LLC
2024-12-12
$0.00/25kg
VIP1Y
Hebei Mojin Biotechnology Co.,Ltd
2024-09-13
$10.70/1KG
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-22
$23.00/1Box
zhuzhou dingcheng meihei comestic co.,ltd
2024-05-30
$0.00/1kg
VIP1Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-04-19
$1.00/1kg
VIP4Y
Dorne Chemical Technology co. LTD
2024-03-26
$45.00/1kg
VIP1Y
Sigma Audley
2024-03-07
$0.00/1kg
VIP1Y
Shandong Hanjiang Chemical Co., Ltd
2024-01-25
$10.00/1kg
VIP1Y
Wuhan Xinhao Biotechnology Co., Ltd
2024-01-18
$10.00/1kg
Nantong Guangyuan Chemicl Co,Ltd
2023-11-17
  • Since: 2014-12-17
  • Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY
楊俊青

sales@coreychem.com